CytomX Therapeutics (CTMX) Return on Equity [ROE] (2015 - 2026)
CytomX Therapeutics (CTMX) posted Return on Equity [ROE] of -25.61% for Q2 2026, down 91.81 percentage points from 66.20% a year earlier but up 2.62 percentage points from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, CytomX Therapeutics' Return on Equity [ROE] came in at -35.25%.
- Annual Return on Equity [ROE] shows a five-year change of +697.31 percentage points (FY2020 to FY2025).
- Quarterly Return on Equity [ROE] has run from a low of -773.16% in Q4 2021 to a high of 338.33% in Q1 2025 over five years.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -28.23% (Q1 2026), -16.83% (Q4 2025) and 24.65% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | CytomX Therapeutics | 592.69 Mn | -364.98 Mn | - | -25.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.61% |
| Mar 31, 2026 | -28.23% |
| Dec 31, 2025 | -16.83% |
| Sep 30, 2025 | 24.65% |
| Jun 30, 2025 | 66.20% |
| Mar 31, 2025 | 338.33% |
| Dec 31, 2021 | -773.16% |
| Sep 30, 2021 | -237.27% |
| Jun 30, 2021 | -142.80% |
| Mar 31, 2021 | -267.93% |
| Dec 31, 2020 | -321.77% |
| Sep 30, 2020 | -199.95% |
| Jun 30, 2020 | -164.13% |
| Mar 31, 2020 | -229.31% |
| Dec 31, 2019 | -246.93% |
| Sep 30, 2019 | -107.85% |
| Jun 30, 2019 | -88.14% |
| Mar 31, 2019 | -64.43% |
| Dec 31, 2018 | -57.66% |
| Sep 30, 2018 | -52.07% |
API Access
CytomX Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();